Corticosteroids pulse therapy and oral corticosteroids therapy for IgA nephropathy patients with advanced chronic kidney disease: results of a multicenter, large-scale, long-term observational cohort study
Abstract Background Corticosteroids are widely used to reduce the urine protein levels of patients with immunoglobulin A nephropathy (IgAN). However, their potential preventive effects on end-stage kidney disease (ESKD) are unclear. Methods We previously performed a large-scale, long-term multicente...
Main Authors: | Ryoya Tsunoda, Joichi Usui, Junichi Hoshino, Takayuki Fujii, Satoshi Suzuki, Kenmei Takaichi, Yoshifumi Ubara, Kunihiro Yamagata |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2018-09-01
|
Series: | BMC Nephrology |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s12882-018-1019-x |
Similar Items
-
Severe Adverse Effects Associated With Corticosteroid Treatment in Patients With IgA Nephropathy
by: Qingqing Cai, et al.
Published: (2017-07-01) -
Comparison of the effects of hydroxychloroquine and corticosteroid treatment on proteinuria in IgA nephropathy: a case-control study
by: Ya-zi Yang, et al.
Published: (2019-08-01) -
Nefropatia por IgA nas espondiloartrites IgA nephropathy in spondyloarthritis
by: Daniela Castelo Azevedo, et al.
Published: (2011-02-01) -
IgA Nephropathy in Salvador, Brazil. Clinical and laboratory presentation at diagnosis
by: Brenda Navarro de Souza, et al.
Published: (2018-05-01) -
Infection-related immunoglobulin A nephropathy or IgA-dominant postinfectious glomerulonephritis; what is in a name?
by: Ghazal Ghasempoor Dabaghi, et al.
Published: (2021-07-01)